PT - JOURNAL ARTICLE AU - Yong Ge AU - Wen-Bin Zhang AU - Haiyan Liu AU - Corrine W Ruktanonchai AU - Maogui Hu AU - Xilin Wu AU - Yongze Song AU - Nick W Ruktanonchai AU - Wei Yan AU - Luzhao Feng AU - Zhongjie Li AU - Weizhong Yang AU - Mengxiao Liu AU - Andrew J Tatem AU - Shengjie Lai TI - Effects of worldwide interventions and vaccination on COVID-19 between waves and countries AID - 10.1101/2021.03.31.21254702 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.31.21254702 4099 - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254702.short 4100 - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254702.full AB - Worldwide governments have rapidly deployed non-pharmaceutical interventions (NPIs) to mitigate the COVID-19 pandemic, together with the large-scale rollout of vaccines since late 2020. However, the effect of these individual NPI and vaccination measures across space and time has not been sufficiently explored. By the decay ratio in the suppression of COVID-19 infections, we investigated the performance of different NPIs across waves in 133 countries, and their integration with vaccine rollouts in 63 countries as of 25 March 2021. The most effective NPIs were gathering restrictions (contributing 27.83% in the infection rate reductions), facial coverings (16.79%) and school closures (10.08%) in the first wave, and changed to facial coverings (30.04%), gathering restrictions (17.51%) and international travel restrictions (9.22%) in the second wave. The impact of NPIs had obvious spatiotemporal variations across countries by waves before vaccine rollouts, with facial coverings being one of the most effective measures consistently. Vaccinations had gradually contributed to the suppression of COVID-19 transmission, from 0.71% and 0.86% within 15 days and 30 days since Day 12 after vaccination, to 1.23% as of 25 March 2021, while NPIs still dominated the pandemic mitigation. Our findings have important implications for continued tailoring of integrated NPI or NPI-vaccination strategies against future COVID-19 waves or similar infectious diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Natural Science Foundation for Distinguished Young Scholars of China (No. 41725006), the National Natural Science Foundation of China (81773498), the Bill & Melinda Gates Foundation (INV-024911 and OPP1134076), and Beijing Natural Science Foundation (Grant No.7212128).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance for collecting and using secondary data in this study was granted by the institutional review board of the University of Southampton (No. 61865). All data were supplied and analysed in an anonymous format, without access to personal identifying information.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll source code and data necessary for the replication of our results and figures are available at: https://github.com/wxl1379457192/NPIs_code https://github.com/wxl1379457192/NPIs_code